Summit Therapeutics and Akeso announced positive results from the Phase III HARMONi-2 trial, evaluating ivonescimab, an investigational bispecific antibody,...
Welcome to the Veeva R&D Quality Summit, where we explore the latest innovations in clinical trials. Today, Richard Young,...
Paige, a leader in artificial intelligence (AI) technology, introduces Paige Albaâ„¢, a clinical-grade AI co-pilot designed to transform personalized...
The U.S. Food & Drug Administration (FDA) recently issued a Letter of Support (LoS) endorsing the use of the...
SEQSTER, a healthcare technology company, and PatientsLikeMe (PLM), an engagement platform, have partnered to harness the power of patient...
Kincell Bio, a cell therapy CDMO, has forged a new partnership to produce early-phase clinical material for an allogeneic...
Chronic hand eczema (CHE) is a prevalent skin condition, affecting approximately 5.6% of adults worldwide. The burden of CHE...
In the complex and highly regulated environment of clinical trials, the Trial Master File (TMF) is a foundational tool...
Arsenal Biosciences, a leading cell therapy company specializing in solid tumor treatment, has secured $325 million in Series C...
eGenesis, a biotechnology company focused on addressing the global organ shortage, has secured $191 million in Series D financing....
